A first-in-class, first-in-human Phase I trial of KPT-330, a Selective Inhibitor of Nuclear Export (SINE) in patients (pts) with advanced solid tumorsA first-in-class, first-in-human Phase I trial of KPT-330, a Selective Inhibitor of Nuclear Export (SINE) in patients (pts) with advanced solid tumors Learn More